Coping with changes in the Defined Daily Dose in a longitudin drug consumption database

Pharmacy World and Science

Volumn 32, Issue 2, 2010, Pages 125-129

  Vlahović Palčevski, Vera ^a,b   Gantumur, Monja ^a   Radošević, Nives ^b   Palčevski, Goran ^a   Vander Stichele, Robert ^c  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

ATC coding; Classification; Croatia; Drug utilization; Length of stay; Longitudinal databases; Retrospective studies; World Health Organization

Indexed keywords

ALOSETRON; AMOXICILLIN PLUS CLAVULANIC ACID; BEZITRAMIDE; BUDESONIDE; CABERGOLINE; ERYTHROPOIETIN; ESOMEPRAZOLE; ETIRACETAM; FENTANYL; FOLIC ACID; GALANTAMINE; HYDROMORPHONE; LEFLUNOMIDE; LEVOFLOXACIN; OXYCODONE; REPAGLINIDE; RISEDRONIC ACID; ROFECOXIB; SUMATRIPTAN;

ARTICLE; CHANGE MANAGEMENT; CONTROLLED STUDY; COPING BEHAVIOR; DATA ANALYSIS; DATA BASE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; HOSPITAL UTILIZATION; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; TREND STUDY;

CROATIA; DATA COLLECTION; DATABASES, FACTUAL; DRUG UTILIZATION; HUMANS; LONGITUDINAL STUDIES; PRESCRIPTION DRUGS; RESEARCH DESIGN;

EID: 77953322573     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9366-0     Document Type: Article

References (12)

1. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/. Last accessed 30 Oct 2009.
2. Rønning M. Coding and classification in drug statistics - from national to global application. Nor J Epidemiol. 2001;1(1):37-40.
3. Wettermark B, Vlahovic-Palcevski V, Salvesen Blix H, Ronning M, Vander Stichele RH. Drug utilization research. In: Hartzema AG, Tilson HH, Chan KA, editors. Pharmacoepidemiology and therapeutic risk management. Cincinnati: Harvey Wittheny; 2008. ISBN 978-0-929375-30-4.
4. World Health Organisation Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo, Norway: WHO; 2009.
5. WHO Collaborating Centre for Drug Statistics methodology. ATC Index with DDD's. Oslo: WHO; 2001.
6. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDD's. Oslo: WHO; 2002.
7. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDD's. Oslo: WHO; 2003.
8. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDD's. Oslo: WHO; 2004.
9. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDD's. Oslo: WHO; 2005.
10. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis. 1998;17(1):20-4.
11. Heerdink ER, Urquhart J, Leufkens HG. Changes in prescribed drug doses after market introduction. Pharmacoepidemiol Drug Saf. 2002;11(6):447-53.
12. Stolk P, Heerdink ER, Leufkens HG. Changes in the defined daily dose; YP2D6/CYP3A metabolism as an indicator for dose-setting problems. Eur J Clin Pharmacol. 2005;61(3):243-6.